Tristel (GB:TSTL) has released an update.
Tristel PLC announces leadership changes with Matt Sassone taking over as CEO following Paul Swinney’s retirement, alongside Bart Leemans’ transition from the Board to focus on expanding the French market. Despite a change in the Board, the company continues its growth trajectory, with France representing a significant opportunity, contributing £3.0 million to the year’s sales. Tristel is known for its proprietary chlorine dioxide chemistry used in infection prevention products and operates globally with a strong presence in the medical device decontamination market.
For further insights into GB:TSTL stock, check out TipRanks’ Stock Analysis page.
